November 17, 2020 07:12 AM ESTUpdated 02:41 PM
Coronavirus

Covid-19 roundup: EU be­gins re­view­ing Mod­er­na vac­cine; Cure­Vac and EU agree to 405M-dose deal

Nicole DeFeudis

Editor

Jason Mast

Editor

A day af­ter an­nounc­ing their vac­cine is high­ly ef­fec­tive at pre­vent­ing Covid-19, Mod­er­na said Eu­ro­pean reg­u­la­tors have be­gun a rolling re­view of the prod­uct …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times